Inhibition of Chk1 kinase sensitizes leukemia and lymphoma cell lines with TP53 mutations to chemotherapy

ZEMANOVÁ, Jana; Ludmila ŠEBEJOVÁ; Ondřej HYLSE; Kamil PARUCH; Šárka PAVLOVÁ; Jiří MAYER; Šárka POSPÍŠILOVÁ and Martin TRBUŠEK. Inhibition of Chk1 kinase sensitizes leukemia and lymphoma cell lines with TP53 mutations to chemotherapy. In 54th ASH Annual Meeting and Exposition, Atlanta, USA in Blood. 2012.

Basic information

Original name

Inhibition of Chk1 kinase sensitizes leukemia and lymphoma cell lines with TP53 mutations to chemotherapy

Authors

ZEMANOVÁ, Jana; Ludmila ŠEBEJOVÁ; Ondřej HYLSE; Kamil PARUCH; Šárka PAVLOVÁ; Jiří MAYER; Šárka POSPÍŠILOVÁ and Martin TRBUŠEK

Edition

54th ASH Annual Meeting and Exposition, Atlanta, USA in Blood, 2012

---

Other information

Type of outcome

Conference abstract

Confidentiality degree

is not subject to a state or trade secret

Organization unit

Central European Institute of Technology

UT WoS

000314049602221

---

Links

CZ.1.07/2.4.00/17.0042, interní kód MU	Name: InterBioNet - Podpora mezinárodní a mezisektorové spolupráce ve výzkumu a vývoji v oblasti věd o živé přírodě Investor: Ministry of Education, Youth and Sports of the CR, 2.4 Partnership and networks
MUNI/A/0784/2011, interní kód MU	Name: Nové diagnostické a klinické přístupy v onkologii (Acronym: NoDiKliPO) Investor: Masaryk University, Category A